These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 21308491)

  • 1. Heterogeneity of human monocytes: an optimized four-color flow cytometry protocol for analysis of monocyte subsets.
    Tallone T; Turconi G; Soldati G; Pedrazzini G; Moccetti T; Vassalli G
    J Cardiovasc Transl Res; 2011 Apr; 4(2):211-9. PubMed ID: 21308491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry.
    Thomas GD; Hamers AAJ; Nakao C; Marcovecchio P; Taylor AM; McSkimming C; Nguyen AT; McNamara CA; Hedrick CC
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1548-1558. PubMed ID: 28596372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) /CD16(neg) monocytes: Expansion of CD14(hi) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocytes in acute liver failure.
    Abeles RD; McPhail MJ; Sowter D; Antoniades CG; Vergis N; Vijay GK; Xystrakis E; Khamri W; Shawcross DL; Ma Y; Wendon JA; Vergani D
    Cytometry A; 2012 Oct; 81(10):823-34. PubMed ID: 22837127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD14
    Urbanski K; Ludew D; Filip G; Filip M; Sagan A; Szczepaniak P; Grudzien G; Sadowski J; Jasiewicz-Honkisz B; Sliwa T; Kapelak B; McGinnigle E; Mikolajczyk T; Guzik TJ
    Thromb Haemost; 2017 May; 117(5):971-980. PubMed ID: 28229168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis.
    Xiang Y; Liang B; Zhang X; Zheng F
    Int J Med Sci; 2020; 17(14):2171-2179. PubMed ID: 32922178
    [No Abstract]   [Full Text] [Related]  

  • 6. A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets.
    Ong SM; Teng K; Newell E; Chen H; Chen J; Loy T; Yeo TW; Fink K; Wong SC
    Front Immunol; 2019; 10():1761. PubMed ID: 31402918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Monocyte Heterogeneity as Revealed by High-Dimensional Mass Cytometry.
    Hamers AAJ; Dinh HQ; Thomas GD; Marcovecchio P; Blatchley A; Nakao CS; Kim C; McSkimming C; Taylor AM; Nguyen AT; McNamara CA; Hedrick CC
    Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):25-36. PubMed ID: 30580568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Human Peripheral Monocyte Subsets for Future Coronary Events in Patients Without Significant Coronary Artery Stenosis.
    Kashiwagi M; Imanishi T; Ozaki Y; Taruya A; Nishiguchi T; Katayama Y; Tanimoto T; Kuroi A; Kubo T; Tanaka A; Akasaka T
    Circ J; 2019 Oct; 83(11):2250-2256. PubMed ID: 31511449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating CD14+CD16+ monocyte subsets as biomarkers of the severity of coronary artery disease in patients with stable angina pectoris.
    Ozaki Y; Imanishi T; Taruya A; Aoki H; Masuno T; Shiono Y; Komukai K; Tanimoto T; Kitabata H; Akasaka T
    Circ J; 2012; 76(10):2412-8. PubMed ID: 22785372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris.
    Kashiwagi M; Imanishi T; Tsujioka H; Ikejima H; Kuroi A; Ozaki Y; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Hirata K; Akasaka T
    Atherosclerosis; 2010 Sep; 212(1):171-6. PubMed ID: 20684824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of CD14
    Yamamoto H; Yoshida N; Shinke T; Otake H; Kuroda M; Sakaguchi K; Hirota Y; Toba T; Takahashi H; Terashita D; Uzu K; Tahara N; Shinkura Y; Kuroda K; Nagasawa Y; Nagano Y; Tsukiyama Y; Yanaka KI; Emoto T; Sasaki N; Yamashita T; Ogawa W; Hirata KI
    Atherosclerosis; 2018 Feb; 269():245-251. PubMed ID: 29407600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of EMMPRIN (CD147) on monocyte subsets in patients with symptomatic coronary artery disease.
    Sturhan H; Ungern-Sternberg SN; Langer H; Gawaz M; Geisler T; May AE; Seizer P
    Thromb Res; 2015 Jun; 135(6):1160-4. PubMed ID: 25824988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis.
    Shantsila E; Tapp LD; Wrigley BJ; Pamukcu B; Apostolakis S; Montoro-García S; Lip GY
    Atherosclerosis; 2014 May; 234(1):4-10. PubMed ID: 24583499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD14++ CD16+ HLA-DR+ Monocytes in Peripheral Blood are Quantitatively Correlated with the Severity of Pre-eclampsia.
    Tang MX; Zhang YH; Hu L; Kwak-Kim J; Liao AH
    Am J Reprod Immunol; 2015 Aug; 74(2):116-22. PubMed ID: 25850575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.
    Rogacev KS; Cremers B; Zawada AM; Seiler S; Binder N; Ege P; Große-Dunker G; Heisel I; Hornof F; Jeken J; Rebling NM; Ulrich C; Scheller B; Böhm M; Fliser D; Heine GH
    J Am Coll Cardiol; 2012 Oct; 60(16):1512-20. PubMed ID: 22999728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardized flow cytometry assay for identification of human monocytic heterogeneity and LRP1 expression in monocyte subpopulations: decreased expression of this receptor in nonclassical monocytes.
    Ferrer DG; Jaldín-Fincati JR; Amigone JL; Capra RH; Collino CJ; Albertini RA; Chiabrando GA
    Cytometry A; 2014 Jul; 85(7):601-10. PubMed ID: 24639232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "Intermediate" CD14
    Wildgruber M; Aschenbrenner T; Wendorff H; Czubba M; Glinzer A; Haller B; Schiemann M; Zimmermann A; Berger H; Eckstein HH; Meier R; Wohlgemuth WA; Libby P; Zernecke A
    Sci Rep; 2016 Dec; 6():39483. PubMed ID: 27991581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease.
    Czepluch FS; Kuschicke H; Dellas C; Riggert J; Hasenfuss G; Schäfer K
    J Intern Med; 2014 Feb; 275(2):144-54. PubMed ID: 24118494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shift of monocyte subsets along their continuum predicts cardiovascular outcomes.
    Cappellari R; D'Anna M; Bonora BM; Rigato M; Cignarella A; Avogaro A; Fadini GP
    Atherosclerosis; 2017 Nov; 266():95-102. PubMed ID: 29017104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.
    Tippett E; Cheng WJ; Westhorpe C; Cameron PU; Brew BJ; Lewin SR; Jaworowski A; Crowe SM
    PLoS One; 2011; 6(5):e19968. PubMed ID: 21625498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.